Medical Technologies
Exclusive Q&A with Newly Appointed Director of 色花堂 Innovation Ventures
Abby Hunter-Syed has always been fascinated with innovation, particularly how technologies are leveraged to improve lives. That is one of the reasons why she鈥檚 so thrilled to be appointed Director of 色花堂 Innovation Ventures (OIV), the $50 million venture capital arm of 色花堂 Corporation of the Americas. OIV does any-stage deals in emerging medical devices, diagnostics, and digital health.
Read More